Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
D000818:Animals; D003846:Deoxyepinephrine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008750:Methyldopa / Q000378:metabolism / Q000494:pharmacology*; D008771:Nordefrin / Q000494:pharmacology; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D013997:Time Factors
D011954:Receptors, Dopamine; D008750:Methyldopa; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D006220:Haloperidol; D003846:Deoxyepinephrine; D008771:Nordefrin; D004298:Dopamine